A successful pregnancy requires that the maternal immune system is instructed to a state of tolerance to avoid rejection of the semi-allogeneic fetal-placental unit. Although increasing evidence supports that decidual (uterine) macrophages and Treg cells are key regulators of fetal tolerance, it is not known how these tolerogenic leukocytes are induced. Here we show that the human fetal placenta itself, mainly through trophoblast cells, is able to induce 3
INTRODUCTION
During pregnancy, immune tolerance is naturally induced to avoid rejection of the semiallogeneic fetal-placental unit. The most prominent changes occur at the fetal-maternal interface, where maternal endometrial leukocytes come into close contact with placental trophoblast cells of paternal origin (1, 2) . During pregnancy, the endometrium becomes a specialized tissue (named decidua) with a strikingly high proportion of leukocytes with unique regulatory functions. Two major regulating populations are the decidual macrophages and regulatory T (Treg) cells that play important roles in establishing tolerance and maintaining the homeostatic environment that is crucial for normal fetal development (3, 4) .
Decidual macrophages are the most abundant antigen presenting cells throughout pregnancy (5) , and they are central in setting the balance between tolerance and pro-inflammatory responses. Human decidual macrophages have properties predominantly associated with homeostatic M2 macrophages, including expression of the homeostatic scavenger receptor CD163, the pattern recognition receptors CD206 and CD209, and the preferential production of cytokines and chemokines like IL-10, CCL2 and CCL18 (6) (7) (8) (9) (10) (11) . Decidual macrophages are also functionally regulatory, being able to suppress the production of IFN-γ by T cells (12) and to induce Treg cells in vitro (13, 14) . Treg cells are essential to the establishment and maintenance of pregnancy, as shown by murine studies (15, 16) . Given their crucial role in The microenvironment has a great influence on leukocyte development, and thus the placenta, being a newly developed and temporary organ closely associated with decidual leukocytes, is a potential candidate for inducing the maternal immune tolerance that is needed for protecting both itself and the fetus. Noteworthy, although the placenta is known to be an important source of immune modulating factors (2) , the capability and relative contribution of these factors in the induction of regulatory decidual leukocytes has not been addressed in a physiological setting. Here we show that the human fetal placenta itself, particularly through trophoblast cells, is able to create a homeostatic and tolerant environment by producing soluble factors (M-CSF, IL-10, TGF-β and TRAIL) that induce the polarization of homeostatic macrophages and the expansion of Treg cells and also limit excessive Th cell activation.
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MATERIALS AND METHODS
Subjects
First trimester placental tissues were collected from 45 healthy pregnant women (median age 25, range 16-42) undergoing elective surgical abortions at Linköping University Hospital, Sweden (n=29) and at the Royal Victoria Infirmary, Newcastle upon Tyne, UK (n=16). All pregnancies were viable and the median gestational week was 9 (range 7-11) as determined by crown-rump length by using ultrasound. Misoprostol (Cytotec®, Searle) was given to all women prior to surgery. The median number of previous pregnancies was 1 (range 0-12) and the median number of previous births was 1 (range 0-5). For the in vitro assays, all blood samples were collected on one or more occasions from 23 healthy non-pregnant female volunteers (median age 27, range 21-44) not taking hormonal contraceptives or any other medication. The time point of sample collection was evenly distributed across the menstrual cycle. All samples were collected after obtaining informed consent (including the parents' consent in the one case where the donor was under the age of 18) and the study was approved by the Local Ethics Committees of Linköping University and Newcastle and North Tyneside.
Placental tissues and cells
Placental explants. Immediately after collection, the maternal part of the placenta (also called decidua) was removed and the fetal placental tissue was further processed. The fetal placenta (hereafter mostly referred to as placenta) was rinsed with sterile saline to remove traces of maternal blood, transported to the laboratory and washed in sterile PBS. The placental villi were then dissected into small pieces (~1-2 mm in diameter) and placed in 24-well plates with culture medium consisting of RPMI 1640 (Gibco-Invitrogen, BRL)
supplemented with 10% heat-inactivated FBS (PAA Laboratories) and 1% PEST/Lglutamine (Gibco-Invitrogen, BRL). A total of ~50-100 mg of wet tissue was added to each 6 well, with 10 µl culture medium per mg of tissue. The placental explants were incubated for ~20-24 h at 37 • C and 5% CO2. The conditioned medium (CM) was then collected, centrifuged and stored in aliquots at -70 • C.
Isolation of trophoblast cells. Extravillous trophoblast (EVT) and cytotrophoblast (CTB)
cells were isolated from placental chorionic villi as previously described (19) . Briefly, placental villi were enzymatically digested 3 x 25 min at 37 °C in 0.125% trypsin (BD Biosciences) and 0.5 mg DNase I (Sigma). At the end of each digest, supernatants were removed, combined with newborn calf serum (5% v:v) (Sigma), centrifuged and cell pellets resuspended in culture medium. Cell suspensions (digest 1 and 2 combined: EVT, digest 3:
CTB) were layered onto a Percoll (Sigma) gradient (10% -70% Percoll) and centrifuged for 30 min (1200 x g, no brake) after which the EVT or CTB cells were collected from the 35-45% Percoll layer. EVT and CTB cells (1x10 6 cells/ml) were plated in 24-well plates coated with growth factor-reduced Matrigel (BD Biosciences) or fibronectin (Sigma-Aldrich), respectively. Cells were cultured for 24 h at 37 • C and 5% CO2. The CM was then collected, centrifuged and stored at -80 • C. The purity of isolated EVT and CTB cells was confirmed to be >97% by immunostaining for cytokeratin 7 (all trophoblast cells) and HLA-G (EVT) as previously described (19) .
HTR-8/SVneo trophoblast cell line.
The first trimester trophoblast cell line HTR-8/SVneo (20) , kindly provided by S. Sharma (Brown University, Providence, RI), was grown in culture medium, consisting of RPMI 1640 supplemented with 5% FBS and 1% PEST/Lglutamine, to ~70-80% confluence. After 3-4 passages, adherent cells were removed enzymatically with 0.25% trypsin-EDTA (Sigma-Aldrich). The cells were then transferred to 24-well plates to a density of 1x10 6 cells/ml and incubated for 24 h at 37 • C and 5% CO2. The CM was then collected, centrifuged and stored at -70 • C. Table I ).
Isolation of blood cells
Macrophages. Macrophages were generated in 24-well plates as previously described (6) , in the presence of 5 ng/mL recombinant human GM-CSF or 50 ng/mL M-CSF (Peprotech) and the addition of CM. Blocking experiments were performed with neutralizing Abs against IL-10R or M-CSF and were added one hour prior to the addition of CM (for Ab details, see
Supplemental Table I ). 
Th cell suppression assay
To test whether the placental explant CM (PE CM)-induced Treg cells were functional, we sorted CD4 dim CD25 high Treg cells and tested their ability to suppress the proliferation of anti-CD3/CD28-stimulated responder T cells by using the cell division-tracking dye CFSE.
Isolated CD4 + T cells were cultured for five days in the presence of 6.25% PE CM, without additional stimulation, as described above. On day five, cells were harvested and stained with CD4 PE-Cy7 and CD25 APC (BD Biosciences) for subsequent flow cytometry sorting. in T cell culture medium for five days at 37°C and 5% CO2. Cells were then harvested, resuspended in PBS 0.1% FBS and analyzed as described above. Cells were analyzed by using FACSCanto II.
Analysis of cytokines and chemokines with multiplex bead assay
Multiplex bead assay kits were used according to the manufacturer's protocols (Millipore) to analyze CM from placental explants, CTB, EVT and HTR-8/SVneo cells for the detection of the following factors (detection limits are given in brackets): GM-CSF (1.5 pg/ml), M-CSF (98 pg/ml), IL-10 (0.7 pg/ml), TGF-β1-3 (9.8 pg/ml), IL-1RA (16 pg/ml), IL-1β (3.2 pg/ml), IL-6 (16 pg/ml), TNF (3.2 pg/ml), IL-12p70 (3.0 pg/ml), IL-23 (48 pg/ml), IFN-γ (3.2 pg/ml), IL-13 (16 pg/ml), IL-17 (3.2 pg/ml), IL-2 (3.2 pg/ml), TRAIL (2.4 pg/ml), IL-33 (2.8 pg/ml), LIF (3.6 pg/ml), TSLP (2.4 pg/ml), CCL2 (16 pg/ml), CXCL1-3 (16 pg/ml), CXCL8 (3.2 pg/ml), CXCL10 (16 pg/ml), CXCL11 (11 pg/ml), CCL17 (0.5 pg/ml), CCL20 (9.8 pg/ml) and CCL22 (16 pg/ml). Supernatants from Th cell cultures were analyzed for GM-CSF, IL-2, 
CCL18 ELISA
Quantification of CCL18 in CM from placental explants, CTB, EVT and HTR-8/SVneo cells, and macrophages polarized with PE CM was performed with an in-house double-Ab sandwich ELISA (VersaMax, Molecular Devices), as previously described (22) . The detection limit was 7.8 pg/ml. For calculating the concentration of CCL18 produced by macrophages stimulated with CM, the concentration in the corresponding control CM was subtracted from the concentration measured in the cell supernatants.
Immunohistochemistry
Formalin-fixed and paraffin-embedded placental tissue sections (4 µm), mounted on Superfrost Plus slides (Thermo Scientific), were deparaffinized by washing three times with Histoclear (Histolab), and progressively rehydrated from 100% to 50% ethanol and finally placed in distilled water. All washing between incubations was performed with PBS-Tween (0.05%, Medicago) with a final wash in distilled water. Antigen retrieval was performed for GM-CSF, IL-10 and CD163 by microwave exposure for 20 min in 10 mM Tris-1 mM EDTA, pH 9. Sections were incubated overnight at 4°C with mouse primary mAbs against GM-CSF, M-CSF, IL-10, CD14 or CD163 (for Ab details, see Supplemental Table I ), all diluted in PBS containing 3% normal goat serum (Dako) and 1% Triton X-100 (Sigma-Aldrich). CD14 and CD163 were used to identify placental macrophages (Hofbauer cells). As negative controls, the primary Abs were omitted, and as positive controls, tonsils were immunostained. After washing, sections were incubated for 30 min with polyclonal goat-anti-mouse secondary Abs conjugated with biotin (Dako), diluted 1:300 in PBS containing 3% normal goat serum and 1% Triton X-100. Sections were washed and endogenous peroxidase activity was blocked by incubating the sections with 3% hydrogen peroxide (Sigma-Aldrich) for 20 min.
Immunostaining was developed using the Vectastain ABC kit and DAB as substrate (Vector Labs). Slides were mounted with ImmunoHistoMount (Sigma-Aldrich). Visualization and photography was carried out by using an RFCA microscope and DP50 camera, and the Studio 3.0.1 software (Olympus).
Real Time RT-PCR
Expression of Foxp3 mRNA was analyzed in CD4 + T cells polarized with PE CM for five days, as described above. The PE CM-induced CD4 + T cells were lysed in RNeasy RLT lysing buffer (Qiagen) and frozen at -70˚C until total cellular RNA was isolated with an RNeasy Mini Kit according to the manufacturer's instructions (Qiagen). Quantification of RNA was carried out using an ND-100 NanoDrop (Nanodrop Technologies). The isolated RNA was converted to cDNA using the High Capacity cDNA Reverse Transcription Kit 5′-GCTGGAATTACCGCGGCT-3′, Probe: 5′-TGCTGGCACCAGACTTGCCCTC-3′). The reactions were performed according to the recommended TaqMan protocol using the 7500
Fast Real-Time PCR System (Applied Biosystems). Samples were run in duplicates and the RNA content in all samples was normalized to the expression of 18S rRNA. All data was analyzed with the SDS 2.3 version (Applied Biosystems) and quantification was performed using the standard curve method.
Data analysis and statistics
All data were analyzed by using GraphPad Prism version 6.0. 
RESULTS
Soluble placental factors induce homeostatic M2 macrophages
To assess how decidual macrophages acquire their homeostatic M2 characteristics, we mimicked the decidual macrophage microenvironment by culturing macrophages with conditioned medium (CM) from first trimester placental tissue explants. Macrophages were generated from CD14 + monocytes isolated from non-pregnant women. GM-CSF was used as ( Fig. 1, A and B) . This phenotype was induced in a dose-dependent manner (Fig. 1B) . PE CM (12.5%) also significantly increased the production of the anti-inflammatory cytokine IL-10, while it did not affect IL-12 or IL-23 production (associated with an M1 phenotype and Th1 and Th17 induction, respectively) (23) (Fig. 1C) . The chemokine CCL18, typically produced by homeostatic M2 macrophages and by human decidual macrophages (8), was also induced by PE CM (Fig. 1C) . The production of TGF-β1 did not differ between macrophages stimulated with GM-CSF alone or in combination with PE CM (Fig. 1C) , and TGF-β2/TGF-β3 were under the detection limit regardless of stimulation.
Soluble placental factors preferentially induce Foxp3 + Th cells and IL-10 production
Treg cells are, in contrast to other Th subsets, enriched in the early human decidua (17, 18) .
To analyze whether placental-derived factors could be responsible for the unique composition of Th cell subsets, we cultured CD4 + T cells (isolated from non-pregnant women) in the presence of PE CM. In order to mimic the decidual microenvironment at the resting state, CD4 + T cells were cultured with PE CM without any additional stimulation ("unstimulated").
Unstimulated CD4 + T cells exposed to 6.25% and 12.5% PE CM showed an increased proportion of Foxp3-expressing cells (Treg) (Fig. 2A, "unstim" ). This increase was paralleled by an increased production of IL-10 but not TGF-β1 ( Fig. 2A, "unstim") . TGF-β2 and TGF-β3 were not detected in unstimulated Th cells, neither in the presence nor absence of PE CM.
Although the proportion of T-bet + cells (Th1) also was increased in unstimulated cells, this was not mirrored by increased IFN-γ production ( Fig. 2A, "unstim") . (Fig. 3A) . PE CM also increased the expression of Foxp3 at the mRNA level in unstimulated CD4 + T cells (Fig. 3B) . The PE CM-induced Treg cells were CD127 low , expressed high levels of the suppressive markers CTLA-4 and CD39 and the majority were memory cells expressing CD45R0 (Fig. 3C) , similar to the Treg cells in early human decidua (17, 18 ). 
Cytotrophoblast and extravillous trophoblast cells induce homeostatic macrophages and the expansion of Treg cells
Next we tested whether trophoblast cells, the primary cell component of the fetal placenta, could take part in the induction of homeostatic macrophages and Treg cells. Fig. 5 ; a complete list is presented in Table I ). We have previously shown that the decidual macrophage phenotype can be induced in vitro by M-CSF, while GM-CSF counteracts this effect (6) . We also showed that IL-10 not only enhanced the decidual macrophage phenotype in M-CSF-driven macrophages, but also restored the M2 phenotype in GM-CSF-driven M1-like macrophages (6) . In the present study, we show that the placenta itself is a major source of M-CSF (greatly exceeding the levels of GM-CSF) ( Fig. 5A and Table I ) and that M-CSF is located to CTB cells and the syncytiotrophoblast shell surrounding the chorionic villi (Fig. 5E) . To evaluate the importance of M-CSF in the induction of decidual macrophages, we used anti-M-CSF blocking Abs during the polarization process with PE CM. As seen in Fig. 6A , the induction of CD163 was partially reduced when M-CSF was neutralized, while CD14, CD206 and CD209 were not affected.
IL-10 was also produced by placental tissue and at particularly high levels by CTB and EVT cells, while HTR-8/SVneo cells lacked IL-10 production ( Fig. 5B and Table I ). IL-10 was expressed by CTB cells and the syncytiotrophoblast, but also by other cells, including placental macrophages (Hofbauer cells) (Fig. 5G) . When using blocking Abs against IL-10R, the expression of CD14, CD163, CD206 and CD209 induced by PE CM was significantly reduced in macrophages (Fig. 6B) . These results indicate an important role for trophoblast- Treg cells in the periphery (25, 26) . TGF-β1 and TGF-β2 were detected in PE CM and HTR-8/SVneo CM, while only TGF-β2 was detected in CTB and EVT CM (Fig. 5C and Table I ).
In contrast, TGF-β3 was only detected at low levels in PE CM (Table I ). This correlates well with the previously reported localization of TGF-β1-3 in human placental tissue (27) .
Neutralizing Abs against TGF-β1-3 partially reduced the increased proportion of CD4 + Foxp3 + Treg cells induced by PE CM (Fig. 6C) . A similar reduction in Foxp3 + cells was observed when CD4 + T cells were cultured in the presence of anti-IL-10R Abs (Fig. 6D ).
Placental explants and trophoblast cells also produced the apoptosis-inducing factor TRAIL ( Fig. 5D and Table I ), which was recently localized mainly to the syncytiotrophoblast within the placenta (28) . TRAIL has been shown to preferentially expand the Treg cell population and to inhibit expansion of the non-Treg cell pool in a mouse model (29) . Since we observed that PE CM significantly reduced the viability of unstimulated CD4 + T cells (Fig. 2C, "unstim"), we investigated whether this mechanism could apply to the PE CM-induced Treg cell expansion. Indeed, when using anti-TRAIL blocking Abs we observed a significant reduction in the proportion of PE CM-induced Foxp3 + Treg cells (Fig. 6E) . Other factors 
DISCUSSION
In this study, we demonstrate that human fetally-derived placental tissue promotes the induction of homeostatic macrophages and Treg cells, which are essential for fetal tolerance and reproductive success (Fig. 7) . itself is a main inducer of maternal immune cell adaptation. Thus, it seems reasonable that the fetal placenta, as a temporary organ, is the primary trigger of maternal immune cell adaptation. Consequently, although important, the crosstalk between the induced tolerogenic leukocytes might be a secondary mechanism necessary to sustain and enhance fetal tolerance.
In addition, our results indicate that trophoblast cells play a major role in this adaptation.
Although other placental cells have been reported to promote suppressive function in leukocytes (for instance mesenchymal stem cells) (34, 35) , the numerical advantage and anatomical location of trophoblast cells render them the prime candidate for affecting maternal leukocytes in the adjacent decidua. Importantly, the trophoblast cell line HTR-8/SVneo (20) that is widely used as a substitute for human primary trophoblast cells, only partially induced the regulatory cell types described above, and contrary to placental tissue, it enhanced Th cell activation (likely due to their lack of IL-10 production). Thus, although useful in many aspects, results obtained from this cell line should be interpreted with caution.
In contrast to the initially proposed and still predominant Th2 paradigm (36), the specific polarization of homeostatic M2 macrophages and the preferential expansion of Treg cells, but not of Th2 cells, supports the view of a tolerogenic and homeostatic, rather than a Th2-dominated, uterine environment during human pregnancy. This is in agreement with earlier reports showing that Th2 cytokines (IL-4 and IL-13) induce macrophages distinct from decidual macrophages (CD14 low CD163 -) (6) , that Treg cells but not Th2 cells are enriched in first trimester human decidua (17) , and that high levels of IL-10, in relation to IL-4 (37) and IL-13 (Table I) , are present at the fetal-maternal interface. Furthermore, placental-derived soluble factors promoted a general downregulation of Th cell activation and cytokine production in anti-CD3/CD28-stimulated cells. These data indicate a mechanism where placental tissue prevents excessive T cell activation, irrespective of the type of response (e.g.
Th1-, Th2-or Th17-associated). Considering that fetal rejection might not only be caused by activation of placental/fetal-specific T cells but also by general T cell activation, for instance during infections (38, 39) , the ability of the placenta to induce immune cells with a reduced inflammatory potential might be an important contributing mechanism for maintained tissue integrity at the fetal maternal-interface.
Among the factors spontaneously produced by the placental tissue, we identified M-CSF and IL-10 as central for the polarization of homeostatic decidual macrophages. Although we have previously shown by an in vitro model that these cytokines are main inducers of decidual macrophages (6), the present study further strengthens their relevance in vivo, since the effects of M-CSF and IL-10 were apparent at physiological levels, as part of the natural pool of placental-derived cytokines. Of note, these homeostatic M2 characteristics were observed in macrophages generated in the presence of GM-CSF, which alone promotes M1-like macrophages. In addition to the well-known role of M-CSF in macrophage differentiation (40) , local M-CSF production has been proposed as a general inducer of tissue macrophages with an increased threshold for activation, which may be important for sustaining tissue integrity (41) . Similarly, IL-10 is a homeostatic cytokine constitutively produced both at the steady state and during inflammation to control excessive inflammatory responses (42) . The relevance of these cytokines in pregnancy is further supported by their increased levels at the fetal-maternal interface (37, 43) , and by observations of increased rates of spontaneous abortions in M-CSF-deficient mice (44) and in mice with a local defect in IL-10 production (45). In addition, both M-CSF-(46) and IL-10-deficient mice (47, 48) show increased susceptibility to infection-induced fetal loss. Thus, it is likely that placental-derived M-CSF and IL-10 promote macrophages that prevent rejection of the allogeneic fetus by creating a homeostatic microenvironment, and in addition, protect the mother and the fetus against infections without compromising fetal survival. 
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In summary, we have demonstrated that the fetal placenta itself, particularly through trophoblast cells, is able to create a tolerant uterine environment by the production of soluble mediators (M-CSF, IL-10, TGF-β and TRAIL) that induce homeostatic macrophages and Treg cells and limit excessive Th cell activation (Fig. 7) . 
